These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 21979867

  • 1. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients.
    Xia Z, Yang R, Wang W, Cong L.
    Mycopathologia; 2012 Mar; 173(2-3):127-33. PubMed ID: 21979867
    [Abstract] [Full Text] [Related]

  • 2. Molecular identification, genotyping, and antifungal susceptibility testing of clinically relevant Trichosporon species from Argentina.
    Taverna CG, Córdoba S, Murisengo OA, Vivot W, Davel G, Bosco-Borgeat ME.
    Med Mycol; 2014 May; 52(4):356-66. PubMed ID: 24682113
    [Abstract] [Full Text] [Related]

  • 3. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
    Sun W, Su J, Xu S, Yan D.
    J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
    [Abstract] [Full Text] [Related]

  • 4. Invasive Infections Due to Trichosporon: Species Distribution, Genotyping, and Antifungal Susceptibilities from a Multicenter Study in China.
    Guo LN, Yu SY, Hsueh PR, Al-Hatmi AMS, Meis JF, Hagen F, Xiao M, Wang H, Barresi C, Zhou ML, de Hoog GS, Xu YC.
    J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30463892
    [Abstract] [Full Text] [Related]

  • 5. Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients.
    Kalkanci A, Sugita T, Arikan S, Yucesoy M, Ener B, Otag F, Kiraz N, Kustimur S, Sancak B, Evci C, Emektas G.
    Med Mycol; 2010 Feb; 48(1):141-6. PubMed ID: 19462333
    [Abstract] [Full Text] [Related]

  • 6. Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients.
    Mekha N, Sugita T, Ikeda R, Nishikawa A, Autthateinchai R, Poonwan N, Sawanpanyalert P.
    Mycopathologia; 2010 Jan; 169(1):67-70. PubMed ID: 19609716
    [Abstract] [Full Text] [Related]

  • 7. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing.
    Chagas-Neto TC, Chaves GM, Melo AS, Colombo AL.
    J Clin Microbiol; 2009 Apr; 47(4):1074-81. PubMed ID: 19225102
    [Abstract] [Full Text] [Related]

  • 8. Molecular Identification, Genotyping, Phenotyping, and Antifungal Susceptibilities of Medically Important Trichosporon, Apiotrichum, and Cutaneotrichosporon Species.
    do Espírito Santo EPT, Monteiro RC, da Costa ARF, Marques-da-Silva SH.
    Mycopathologia; 2020 Apr; 185(2):307-317. PubMed ID: 31776790
    [Abstract] [Full Text] [Related]

  • 9. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
    Mariné M, Bom VL, de Castro PA, Winkelstroter LK, Ramalho LN, Brown NA, Goldman GH.
    Virulence; 2015 Apr; 6(5):476-86. PubMed ID: 25751127
    [Abstract] [Full Text] [Related]

  • 10. MALDI-TOF MS characterisation, genetic diversity and antifungal susceptibility of Trichosporon species from Iranian clinical samples.
    Ahangarkani F, Ilkit M, Vaseghi N, Zahedi N, Zomorodian K, Khodavaisy S, Afsarian MH, Abbasi K, de Groot T, Meis JF, Badali H.
    Mycoses; 2021 Aug; 64(8):918-925. PubMed ID: 33998718
    [Abstract] [Full Text] [Related]

  • 11. Genotyping, extracellular compounds, and antifungal susceptibility testing of Trichosporon asahii isolated from Mexican patients.
    Montoya AM, Sánchez González A, Palma-Nicolás JP, Gómez-Treviño A, González JG, González GM.
    Med Mycol; 2015 Jun; 53(5):505-11. PubMed ID: 25980003
    [Abstract] [Full Text] [Related]

  • 12. Intergenic spacer (IGS-1) region sequence-based identification, genotypic analysis, and antifungal susceptibility of clinical Trichosporon species.
    Parashar A, Rastogi V, Prakash H, Pandey A, Rudramurthy SM.
    Indian J Med Microbiol; 2023 Jun; 45():100390. PubMed ID: 37573054
    [Abstract] [Full Text] [Related]

  • 13. Sequence-based identification, genotyping and EUCAST antifungal susceptibilities of Trichosporon clinical isolates from Greece.
    Arabatzis M, Abel P, Kanellopoulou M, Adamou D, Alexandrou-Athanasoulis H, Stathi A, Platsouka E, Milioni A, Pangalis A, Velegraki A.
    Clin Microbiol Infect; 2014 Aug; 20(8):777-83. PubMed ID: 24330082
    [Abstract] [Full Text] [Related]

  • 14. Three-locus identification, genotyping, and antifungal susceptibilities of medically important Trichosporon species from China.
    Guo LN, Xiao M, Kong F, Chen SC, Wang H, Sorrell TC, Jiang W, Dou HT, Li RY, Xu YC.
    J Clin Microbiol; 2011 Nov; 49(11):3805-11. PubMed ID: 21900517
    [Abstract] [Full Text] [Related]

  • 15. Genotype analysis based on intergenic spacer 1 sequences of Trichosporon asahii collected in Taiwan.
    Yang YL, Liu YW, Chen HT, Tsai MS, Chu WL, Lo HJ.
    Med Mycol; 2013 Nov; 51(8):880-3. PubMed ID: 23768241
    [Abstract] [Full Text] [Related]

  • 16. Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India.
    Rastogi V, Honnavar P, Rudramurthy SM, Pamidi U, Ghosh A, Chakrabarti A.
    Mycoses; 2016 Aug; 59(8):528-34. PubMed ID: 27144725
    [Abstract] [Full Text] [Related]

  • 17. Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen.
    Dabas Y, Xess I, Kale P.
    Med Mycol; 2017 Jul 01; 55(5):518-527. PubMed ID: 27816903
    [Abstract] [Full Text] [Related]

  • 18. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres.
    Francisco EC, de Almeida Junior JN, de Queiroz Telles F, Aquino VR, Mendes AVA, de Andrade Barberino MGM, de Tarso O Castro P, Guimarães T, Hahn RC, Padovan ACB, Chaves GM, Colombo AL.
    Clin Microbiol Infect; 2019 Jul 01; 25(7):909.e1-909.e5. PubMed ID: 30991116
    [Abstract] [Full Text] [Related]

  • 19. Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.
    Tsai MS, Yang YL, Wang AH, Wang LS, Lu DC, Liou CH, Hsieh LY, Wu CJ, Cheng MF, Shi ZY, Lo HJ.
    Mycopathologia; 2012 Aug 01; 174(2):121-30. PubMed ID: 22318636
    [Abstract] [Full Text] [Related]

  • 20. In Vitro Activity of Berberine Alone and in Combination with Antifungal Drugs Against Planktonic Forms and Biofilms of Trichosporon Asahii.
    Cong L, Liao Y, Yang S, Yang R.
    Mycopathologia; 2017 Oct 01; 182(9-10):829-837. PubMed ID: 28144822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.